|
Ahn M, Zhang HHelen, Lu W. "Moment-based method for random effects selection in linear mixed models." Stat Sin.;22(4):1539-1562. PubMed |
|
Amorim LDAF, Cai J. "Modelling recurrent events: A tutorial for analysis in epidemiology." Int J Epidemiol.;44(1):324-33. PubMed |
|
Amorim LDAF, Cai J, Zeng D. "Proportional rate models for recurrent time event data under dependent censoring: A comparative study.;4:123-141. |
|
Anderson GR, Wardell SE, Cakir M, Crawford L, Leeds JC, Nussbaum DP, Shankar PS, Soderquist RS, Stein EM, Tingley JP, Winter PS, Zieser-Misenheimer EK, Alley HM, Yllanes A, Haney V, Blackwell KL, McCall SJ, McDonnell DP, Wood KC. "PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation." Sci Transl Med.;8(369):369ra175. PubMed |
|
Barry WT, Perou CM, Marcom K, Carey LA, Ibrahim JG. "The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies." J Biopharm Stat.;25(1):66-88. PubMed |
|
Bayar MAmine, Ivanova A, Le Teuff G. "CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method." Comput Methods Programs Biomed.;176:211-223. PubMed |
|
Blackwell K, Donskih R, Jones M, Nixon A, Vidal MJ, Nakov R, Singh P, Schaffar G, Gascón P, Harbeck N. "A comparison of proposed biosimilar LA-EP2006 and reference Pegfilgrastim for the prevention of neutropenia in patients with early-stage breast cancer receiving Myelosuppressive adjuvant or Neoadjuvant chemotherapy: Pegfilgrastim Randomized Oncology (Supp" Oncologist.;21(7):789-94. PubMed |
|
Brownstein NC, Cai J, Slade GD, Bair E. "Parameter estimation in Cox models with missing failure indicators and the OPPERA study." Stat Med.;34(30):3984-96. PubMed |
|
Brownstein NC, Cai J. "Tests of trend between disease outcomes and ordinal covariates discretized from underlying continuous variables: simulation studies and applications to NHANES 2007-2008." BMC Med Res Methodol.;19(1):2. PubMed |
|
Burbank AJ, Todoric K, Steele P, Rosen J, Zhou H, Frye M, Loughlin CE, Ivins S, Mills K, Massey LDembnicki, Reeve BB, Hernandez ML. "Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics." Respir Res.;19(1):152. PubMed |
|
Cai J, Zeng D. "Additive mixed effect model for clustered failure time data." Biometrics.;67(4):1340-51. PubMed |
|
Cai N, Lu W, Zhang HHelen. "Time-varying latent effect model for longitudinal data with informative observation times." Biometrics.;68(4):1093-102. PubMed |
|
Calandruccio L, Zhou H. "Increase in speech recognition due to linguistic mismatch between target and masker speech: monolingual and simultaneous bilingual performance." J Speech Lang Hear Res.;57(3):1089-97. PubMed |
|
Cao H, Churpek MM, Zeng D, Fine JP. "Analysis of the proportional hazards model with sparse longitudinal covariates." J Am Stat Assoc.;110(511):1187-1196. PubMed |
|
Cao H, Zeng D, Fine JP. "Regression analysis of sparse asynchronous longitudinal data." J R Stat Soc Series B Stat Methodol.;77(4):755-776. PubMed |
|
Caron WP, Lay JC, Fong AM, La-Beck NM, Kumar P, Newman SE, Zhou H, Monaco JH, Clarke-Pearson DL, Brewster WR, Van Le L, Bae-Jump VL, Gehrig PA, Zamboni WC. "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology." J Pharmacol Exp Ther.;347(3):599-606. PubMed |
|
Chen Q, Zeng D, Ibrahim JG, Akacha M, Schmidli H. "Estimating time-varying effects for overdispersed recurrent events data with treatment switching." Biometrika.;100(2):339-354. PubMed |
|
Chen LM, Ibrahim JG, Chu H. "Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses." J Biopharm Stat.;24(4):817-33. PubMed |
|
Chen Q, May RC, Ibrahim JG, Chu H, Cole SR. "Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates." Stat Med.;33(26):4560-76. PubMed |
|
Chen H, Zeng D, Wang Y. "Penalized nonlinear mixed effects model to identify biomarkers that predict disease progression." Biometrics.;73(4):1343-1354. PubMed |
|
Chen L, Lin DY, Zeng D. "Predictive accuracy of covariates for event times." Biometrika.;99(3):615-630. PubMed |
|
Chen Q, Zeng D, Ibrahim JG, Chen MH, Pan Z, Xue X. "Quantifying the average of the time-varying hazard ratio via a class of transformations." Lifetime Data Anal.;21(2):259-79. PubMed |
|
Chen X, Cai J. "Reweighted estimators for additive hazard model with censoring indicators missing at random." Lifetime Data Anal.;24(2):224-249. PubMed |
|
Chen LM, Ibrahim JG, Chu H. "Sample size and power determination in joint modeling of longitudinal and survival data." Stat Med.;30(18):2295-309. PubMed |
|
Chen LM, Ibrahim JG, Chu H. "Sample size determination in shared frailty models for multivariate time-to-event data." J Biopharm Stat.;24(4):908-23. PubMed |
|
Chen X, Wang Q, Cai J, Shankar V. "Semiparametric additive marginal regression models for multiple type recurrent events." Lifetime Data Anal.;18(4):504-27. PubMed |
|
Cheng G, Zhang HHelen, Shang Z. "Sparse and efficient estimation for partial spline models with increasing dimension." Ann Inst Stat Math.;67(1):93-127. PubMed |
|
Chiuzan C, Shtaynberger J, Manji GA, Duong JK, Schwartz GK, Ivanova A, Lee SM. "Dose-finding designs for trials of molecularly targeted agents and immunotherapies." J Biopharm Stat.;27(3):477-494. PubMed |
|
Choi J, Cai J, Zeng D, Olshan AF. "Joint analysis of survival time and longitudinal categorical outcomes." Stat Biosci.;7(1):19-47. PubMed |
|
Choi J, Zeng D, Olshan AF, Cai J. "Joint modeling of survival time and longitudinal outcomes with flexible random effects." Lifetime Data Anal.;24(1):126-152. PubMed |
|
Chung Y, Ivanova A, Hudgens MG, Fine JP. "Partial likelihood estimation of isotonic proportional hazards models." Biometrika.;105(1):133-148. PubMed |
|
DE Castro M, Chen MH, Zhang Y, D'Amico AV. "A Bayesian multi-risks survival (MRS) model in the presence of double censorings." Biometrics.;76(4):1297-1309. PubMed |
|
Deng Y, Zeng D, Zhao J, Cai J. "Proportional hazards model with a change point for clustered event data." Biometrics.;73(3):835-845. PubMed |
|
Diao G, Dong J, Zeng D, Ke C, Rong A, Ibrahim JG. "Biomarker threshold adaptive designs for survival endpoints." J Biopharm Stat.;28(6):1038-1054. PubMed |
|
Diao G, Zeng D, Yang S. "Efficient semiparametric estimation of short-term and long-term hazard ratios with right-censored data." Biometrics.;69(4):840-9. PubMed |
|
Diéras V, Miles D, Verma S, Pegram M, Welslau M, Baselga J, Krop IE, Blackwell K, Hoersch S, Xu J, Green M, Gianni L. "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial." Lancet Oncol.;18(6):732-742. PubMed |
|
Ding J, Zhou H, Liu Y, Cai J, Longnecker MP. "Estimating effect of environmental contaminants on women's subfecundity for the MoBa study data with an outcome-dependent sampling scheme." Biostatistics.;15(4):636-50. PubMed |
|
Ding J, Lu TS, Cai J, Zhou H. "Recent progresses in outcome-dependent sampling with failure time data." Lifetime Data Anal.;23(1):57-82. PubMed |
|
Esserman D, Zhao Y, Tang Y, Cai J. "Sample size estimation in educational intervention trials with subgroup heterogeneity in only one arm." Stat Med.;32(12):2140-54. PubMed |
|
Fan A, Song R, Lu W. "Change-plane analysis for subgroup detection and sample size calculation." J Am Stat Assoc.;112(518):769-778. PubMed |
|
Farber H, Tsvankin V, Narloch JL, Kim GJ, Salama AKS, Vlahovic G, Blackwell KL, Kirkpatrick JP, Fecci PE. "Embracing rejection: Immunologic trends in brain metastasis." Oncoimmunology.;5(7):e1172153. PubMed |
|
Foster NR, Renfro LA, Schild SE, Redman MW, Wang XF, Dahlberg SE, Ding K, Bradbury PA, Ramalingam SS, Gandara DR, Shibata T, Saijo N, Vokes EE, Adjei AA, Mandrekar SJ. "Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer." J Thorac Oncol.;10(7):1099-106. PubMed |
|
Freedman RA, Gelman RS, Wefel JS, Melisko ME, Hess KR, Connolly RM, Van Poznak CH, Niravath PA, Puhalla SL, Ibrahim N, Blackwell KL, Moy B, Herold C, Liu MC, Lowe A, Agar NYR, Ryabin N, Farooq S, Lawler E, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU. "Translational Breast Cancer Research Consortium (TBCRC) 022: A phase II trial of Neratinib for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases." J Clin Oncol.;34(9):945-52. PubMed |
|
Gao H, Kelsey CR, Boyle J, Xie T, Catalano S, Wang X, Yin FF. "Impact of esophageal motion on dosimetry and toxicity with thoracic radiation therapy." Technol Cancer Res Treat.;18:1533033819849073. PubMed |
|
Gao F, Dong J, Zeng D, Rong A, Ibrahim JG. "Pattern mixture models for clinical validation of biomarkers in the presence of missing data." Stat Med.;36(19):2994-3004. PubMed |
|
George SL, Wang X, Pang H. "Cancer clinical trials: Current and controversial issues in design and analysis.. |
|
George SL, Buyse M. "Data fraud in clinical trials." Clin Investig (Lond).;5(2):161-173. PubMed |
|
George SL. "Design of phase III clinical trials.. |
|
George SL, Wang X, Pang H. "Endpoints for cancer clinical trials.. |
|
George SL, Wang X. "Targeted cancer clinical trials.:157-177. |
|
Ghosh L, Jiang J, Sun Y, Zhou H. "Failure time regression with continuous informative auxiliary covariates." J Stat Distrib Appl.;2:2. PubMed |
|
Hamy AS, Tury S, Wang X, Gao J, Pierga JY, Giacchetti S, Brain E, Pistilli B, Marty M, Espié M, Benchimol G, Laas E, Laé M, Asselain B, Aouchiche B, Edelman M, Reyal F. "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial." J Clin Oncol.;37(8):624-635. PubMed |
|
Hao N, Zhang HHelen. "Interaction screening for ultra-high dimensional data." J Am Stat Assoc.;109(507):1285-1301. PubMed |
|
Harbeck N, Lipatov O, Frolova M, Udovitsa D, Topuzov E, Ganea-Motan DElena, Nakov R, Singh P, Rudy A, Blackwell K. "Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer." Future Oncol.;12(11):1359-67. PubMed |
|
He K, Li Y, Zhu J, Liu H, Lee JE, Amos CI, Hyslop T, Jin J, Lin H, Wei Q, Li Y. "Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates." Bioinformatics.;32(1):50-7. PubMed |
|
Hu W, Cai J, Zeng D. "Sample size/power calculation for stratified case-cohort design." Stat Med.;33(23):3973-85. PubMed |
|
Hua Z, Zhu H, Dunson DB. "Semiparametric Bayes local additive models for longitudinal data." Stat Biosci.;7(1):90-107. PubMed |
|
Hyun JWon, Li Y, Gilmore JH, Lu Z, Styner M, Zhu H. "SGPP: Spatial Gaussian predictive process models for neuroimaging data." Neuroimage.;89:70-80. PubMed |
|
Ibrahim JG, Chen MH, Chu H. "Bayesian methods in clinical trials: A Bayesian analysis of ECOG trials E1684 and E1690." BMC Med Res Methodol.;12:183. PubMed |
|
Ibrahim JG, Gwon Y, Chen MH. "SAS Macro BSMED: Bayesian survival meta-experimental design using historical data.. |
|
Ivanova A, Anderson KM, Rosner GL, Rubin E. "Commentary on "Current Statistical Challenges in Oncology Clinical Trials in the Era of Targeted Therapy" by R. Sridhara, K. He, L. Nie, Y.L Shen, and S. Tang." Stat Biopharm Res.;7(4):357-358. PubMed |
|
Ivanova A, Paul B, Marchenko O, Song G, Patel N, Moschos SJ. "Nine-year change in statistical design, profile, and success rates of Phase II oncology trials." J Biopharm Stat.;26(1):141-9. PubMed |
|
Ivanova A, Wang Y, Foster MC. "The rapid enrollment design for Phase I clinical trials." Stat Med.;35(15):2516-24. PubMed |
|
Ivanova A, Deal AM. "Two-stage design for phase II oncology trials with relaxed futility stopping." Stat Interface.;9(1):93-98. PubMed |
|
Jeng J, Lu W, Peng H. "High-dimensional inference for personalized treatment decision." Electron J Stat.;12(1):2074-2089. PubMed |
|
Jia X, Ivanova A, Lee SM. "Selection of the initial design for the two-stage continual reassessment method." J Biopharm Stat.;27(3):495-506. PubMed |
|
Jiang R, Lu W, Song R, Hudgens MG, Naprvavnik S. "Doubly robust estimation of optimal treatment regimes for survival data-with application to an HIV/AIDS study." Ann Appl Stat.;11(3):1763-1786. PubMed |
|
Joshi N, Fine J, Chu R, Ivanova A. "Estimating the subgroup and testing for treatment effect in a post-hoc analysis of a clinical trial with a biomarker." J Biopharm Stat.;29(4):685-695. PubMed |
|
Jung SH. "Design of phase II non-inferiority trials." Contemp Clin Trials Commun.;7:23-27. PubMed |
|
Jung SH, Chi SAh, Ahn HJoo. "K-Sample comparisons using propensity analysis." Biom J.;61(3):698-713. PubMed |
|
Jung SH, Chow SC. "On sample size calculation for comparing survival curves under general hypothesis testing." J Biopharm Stat.;22(3):485-95. PubMed |
|
Jung SH. "Phase II cancer clinical trials for biomarker-guided treatments." J Biopharm Stat.;28(2):256-263. PubMed |
|
Jung SH, Chang MN, Kang SJ. "Phase II cancer clinical trials with heterogeneous patient populations." J Biopharm Stat.;22(2):312-28. PubMed |
|
Jung SH. "Phase II trials for heterogeneous patient populations with a time-to-event endpoint." Med Res Arch.;5(7). PubMed |
|
Jung SH. "Randomized phase II cancer clinical tirals. |
|
Jung SH, Sargent DJ. "Randomized phase II clinical trials." J Biopharm Stat.;24(4):802-16. PubMed |
|
Jung SH. "Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials." Contemp Clin Trials.;42:9-17. PubMed |
|
Jung SH, Sohn I. "Statistical issues in the design and analysis of nCounter projects." Cancer Inform.;13(Suppl 7):35-43. PubMed |
|
Jung SH, Lee HYun, Chow SC. "Statistical methods for conditional survival analysis. " J Biopharm Stat.;28(5):927-938. PubMed |
|
Jung SH. "Stratified Fisher's exact test and its sample size calculation." Biom J.;56(1):129-40. PubMed |
|
Jung SH, Chen Y, Ahn H. "Type I error control for tree classification." Cancer Inform.;13(Suppl 7):11-8. PubMed |
|
Kang S, Lu W, Liu M. "Efficient estimation for accelerated failure time model under case-cohort and nested case-control sampling." Biometrics.;73(1):114-123. PubMed |
|
Kang C, Qaqish B, Monaco J, Sheridan SL, Cai J. "Kappa statistic for clustered dichotomous responses from physicians and patients." Stat Med.;32(21):3700-19. PubMed |
|
Kang S, Cai J, Chambless L. "Marginal additive hazards model for case-cohort studies with multiple disease outcomes: an application to the Atherosclerosis Risk in Communities (ARIC) study." Biostatistics.;14(1):28-41. PubMed |
|
Kang S, Lu W, Zhang J. "On estimation of the optimal treatment regime with the additive hazards model" Stat Sin.;28(3):1539-1560. PubMed |
|
Kang S, Lu W, Song R. "Subgroup detection and sample size calculation with proportional hazards regression for survival data." Stat Med.;36(29):4646-4659. PubMed |
|
Kim S, Zeng D, Cai J. "Analysis of multiple survival events in generalized case-cohort designs." Biometrics.;74(4):1250-1260. PubMed |
|
Kim S, Cai J, Couper D. "Improving the efficiency of estimation in the additive hazards model for stratified case-cohort design with multiple diseases." Stat Med.;35(2):282-93. PubMed |
|
Kim S, Zeng D, Li Y, Spiegelman D. "Joint modeling of longitudinal and cure-survival data." J Stat Theory Pract.;7(2):324-344. PubMed |
|
Kim S, Zeng D, Chambless L, Li Y. "Joint models of longitudinal data and recurrent events with informative terminal event." Stat Biosci.;4(2):262-281. PubMed |
|
Kim S, Cai J, Lu W. "More efficient estimators for case-cohort studies." Biometrika.;100(3):695-708. PubMed |
|
Kim J, Sohn I, Son DS, Kim DHwan, Ahn T, Jung SH. "Prediction of a time-to-event trait using genome wide SNP data." BMC Bioinformatics.;14:58. PubMed |
|
Kim E, Zeng D. "Semiparametric ROC analysis using accelerated regression models." Stat Sin.;23:829-851. PubMed |
|
Kwak M, Um SW, Jung SH. "Comparison of operational characteristics for binary tests with clustered data." Stat Med.;34(15):2325-33. PubMed |
|
Kwak M, Kim J, Jung SH. "Optimal estimation for regression models on τ-year survival probability." J Biopharm Stat.;25(3):539-47. PubMed |
|
Kwak M, Jung SH. "Optimal two-stage log-rank test for randomized phase II clinical trials." J Biopharm Stat.;27(4):639-658. PubMed |
|
Kwak M, Jung SH. "Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test." Stat Med.;33(12):2004-16. PubMed |
|
Lee H, Hudgens MG, Cai J, Cole SR. "Marginal structural Cox models with case-cohort sampling." Stat Sin.;26(2):509-526. PubMed |
|
Li Z, Wang X, Wu Y, Owzar K. "Sample size calculation for studies with grouped survival data." Stat Med.;37(27):3904-3917. PubMed |
|
Liang B, Tong X, Zeng D, Wang Y. "Semiparametric regression analysis of repeated current status data." Stat Sin.;27(3):1079-1100. PubMed |
|
Lin FC, Cai J, Fine JP, Lai HJ. "Nonparametric estimation of the mean function for recurrent event data with missing event category." Biometrika.;100(3). PubMed |
|
Liu B, Lu W, Zhang J. "Accelerated intensity frailty model for recurrent events data." Biometrics.;70(3):579-87. PubMed |
|
Liu Y, Yuan Z, Cai J, Zhou H. "Marginal hazard regression for correlated failure time data with auxiliary covariates." Lifetime Data Anal.;18(1):116-38. PubMed |
|
Liu Z, Song R, Zeng D, Zhang J. "Principal components adjusted variable screening." Comput Stat Data Anal.;110:134-144. PubMed |
|
Liu Y, Wang Y, Zeng D. "Sequential multiple assignment randomization trials with enrichment design." Biometrics.;73(2):378-390. PubMed |
|
Lu TS, Longnecker MP, Zhou H. "Statistical inferences for data from studies conducted with an aggregated multivariate outcome-dependent sample design." Stat Med.;36(6):985-997. PubMed |
|
Lu W, Zhang HHelen, Zeng D. "Variable selection for optimal treatment decision." Stat Methods Med Res.;22(5):493-504. PubMed |
|
Luo S, Song R, Styner M, Gilmore JH, Zhu H. "FSEM: Functional structural equation models for twin functional data." J Am Stat Assoc.;114(525):344-357. PubMed |
|
Luo S, Chen Y, Su X, Chu H. "mmeta: An R package for multivariate meta-analysis." J Stat Softw.;56(11):11. PubMed |
|
Ma GJulie, Chi E, Ibrahim JG, Parker RA. "Assessing Similarity to Existing Drugs to Decide Whether to Continue Drug Development." Stat Biopharm Res.;4(3):293-300. PubMed |
|
Maitra P, Amorim LDAF, Cai J. "Multiplicative rates model for recurrent events in case-cohort studies." Lifetime Data Anal.;26(1):134-157. PubMed |
|
Michiels S, Potthoff RF, George SL. "Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint." Stat Med.;30(13):1502-18. PubMed |
|
Milanzi E, Molenberghs G, Alonso A, Kenward MG, Tsiatis AA, Davidian M, Verbeke G. "Estimation after a group sequential trial." Stat Biosci.;7(2):187-205. PubMed |
|
Milanzi E, Molenberghs G, Alonso A, Kenward MG, Verbeke G, Tsiatis AA, Davidian M. "Properties of estimators in exponential family settings with observation-based stopping rules." J Biom Biostat.;7(1). PubMed |
|
Musolino A, Campone M, Neven P, Denduluri N, Barrios CH, Cortes J, Blackwell K, Soliman H, Kahan Z, Bonnefoi H, Squires M, Zhang Y, Deudon S, Shi MM, André F. "Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy." Breast Cancer Res.;19(1):18. PubMed |
|
Nasution MD, Wang X. "Statistical issues and advances in cancer precision medicine research." J Biopharm Stat.;28(2):215-216. PubMed |
|
Ni A, Cai J. "A regularized variable selection procedure in additive hazards model with stratified case-cohort design." Lifetime Data Anal.;24(3):443-463. PubMed |
|
Ni A, Cai J. "Tuning parameter selection in Cox proportional hazards model with a diverging number of parameters." Scand Stat Theory Appl.;45(3):557-570. PubMed |
|
Ou FS, Zeng D, Cai J. "Quantile regression models for current status data." J Stat Plan Inference.;178:112-127. PubMed |
|
Palumbo A, Michael Y, Hyslop T. "Latent class model characterization of neighborhood socioeconomic status." Cancer Causes Control.;27(3):445-52. PubMed |
|
Pan Y, Cai J, Kim S, Zhou H. "Regression analysis for secondary response variable in a case-cohort study." Biometrics.;74(3):1014-1022. PubMed |
|
Pan Y, Cai J, Longnecker MP, Zhou H. "Secondary outcome analysis for data from an outcome-dependent sampling design." Stat Med.;37(15):2321-2337. PubMed |
|
Pang HH, Wang X, Stinchcombe TE, Wong ML, Cheng P, Ganti AKishor, Sargent DJ, Zhang Y, Hu C, Mandrekar SJ, Redman MW, Manola JB, Schilsky RL, Cohen HJ, Bradley JD, Adjei AA, Gandara D, Ramalingam SS, Vokes EE. "Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012." J Clin Oncol.;34(33):3992-3999. PubMed |
|
Pang H, George SL, Hui K, Tong T. "Gene selection using iterative feature elimination random forests for survival outcomes." IEEE/ACM Trans Comput Biol Bioinform.;9(5):1422-31. PubMed |
|
Pang H, Jung SH. "Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes." Genet Epidemiol.;37(3):276-82. PubMed |
|
Pang H, Wang X. "Statistical aspect of translational and correlative studies in clinical trials." Chin Clin Oncol.;5(1):11. PubMed |
|
Parke T, Marchenko O, Anisimov V, Ivanova A, Jennison C, Perevozskaya I, Song G. "Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?" J Biopharm Stat.;27(3):457-476. PubMed |
|
Potthoff RF, Halabi S. "A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events." Pharm Stat.;14(4):273-83. PubMed |
|
Psioda MA, Soukup M, Ibrahim JG. "A practical Bayesian adaptive design incorporating data from historical controls." Stat Med.;37(27):4054-4070. PubMed |
|
Psioda MA, Ibrahim JG. "Bayesian clinical trial design using historical data that inform the treatment effect." Biostatistics.;20(3):400-415. PubMed |
|
Psioda MA, Ibrahim JG. "Bayesian design of a survival trial with a cured fraction using historical data." Stat Med.;37(26):3814-3831. PubMed |
|
Psioda MA, Hu K, Zhang Y, Pan J, Ibrahim JG. "Bayesian design of biosimilars clinical programs involving multiple therapeutic indications." Biometrics.;76(2):630-642. PubMed |
|
Ren Z, Davidian M, George SL, Goldberg RM, Wright FA, Tsiatis AA, Kosorok MR. "Research methods for clinical trials in personalized medicine: A systematic review.. |
|
Roe MT, Cyr DD, Eckart D, Schulte PJ, Morse MA, Blackwell KL, Ready NE, Zafar Y, Beaven AW, Strickler JH, Onken JE, Winters KJ, Houterloot L, Zamoryakhin D, Wiviott SD, White HD, Prabhakaran D, Fox KAA, Armstrong PW, Ohman M. "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome." Eur Heart J.;37(4):412-22. PubMed |
|
Sargent DJ, George SL. "Clinical trials data collection: When less is more." J Clin Oncol.;28(34):5019-21. PubMed |
|
Schild SE, Fan W, Stinchcombe TE, Vokes EE, Ramalingam SS, Bradley JD, Kelly K, Pang HH, Wang X. "Toxicity related to radiotherapy dose and targeting strategy: A pooled analysis of cooperative group trials of combined modality therapy for locally advanced non-small cell lung cancer." J Thorac Oncol.;14(2):298-303. PubMed |
|
Shi C, Lu W, Song R. "A massive data framework for M-estimators with cubic-rate." J Am Stat Assoc.;113(524):1698-1709. PubMed |
|
Shi C, Lu W, Song R. "Determining the number of latent factors in statistical multi-relational learning. " J Mach Learn Res.;20. PubMed |
|
Shi C, Song R, Chen Z, Li R. "Linear hypothesis testing for high dimensional generalized linear models." Ann Stat.;47(5):2671-2703. PubMed |
|
Shi C, Song R, Lu W. "On testing conditional qualitative treatment effects." Ann Stat.;47(4):2348-2377. PubMed |
|
Shook-Sa BE, Chen DG, Zhou H. "Using structural equation modeling to assess the links between tobacco smoke exposure, volatile organic compounds, and respiratory function for adolescents aged 6 to 18 in the United States." Int J Environ Res Public Health.;14(10). PubMed |
|
Sinha A, Chi Z, Chen MH. "Bayesian inference of hidden gamma wear process model for survival data with ties." Stat Sin.;25(4):1613-1635. PubMed |
|
Song R, Lu W, Ma S, Jeng J. "Censored rank independence screening for high-dimensional survival data." Biometrika.;101(4):799-814. PubMed |
|
Song G, Ivanova A. "Enrollment and stopping rules for managing toxicity requiring long follow-up in phase II oncology trials." J Biopharm Stat.;25(6):1206-14. PubMed |
|
Stinchcombe TE, Jänne PA, Wang X, Bertino EM, Weiss J, Bazhenova L, Gu L, Lau C, Paweletz C, Jaslowski A, Gerstner GJ, Baggstrom MQ, Graziano S, Bearden J, Vokes EE. "Effect of Erlotinib plus Bevacizumab vs Erlotinib alone on progression-free survival in patients with advanced EGFR-mutant non–small cell lung cancer: A phase 2 randomized clinical trial. " JAMA Oncol.;5(10):1448-1455. PubMed |
|
Stinchcombe TE, Zhang Y, Vokes EE, Schiller JH, Bradley JD, Kelly K, Curran WJ, Schild SE, Movsas B, Clamon G, Govindan R, Blumenschein GR, Socinski MA, Ready NE, Akerley WL, Cohen HJ, Pang HH, Wang X. "Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US National Cancer Institute Cooperative Group Studies." J Clin Oncol.;35(25):2885-2892. PubMed |
|
Su L, Lu W, Song R. "Modelling and estimation for optimal treatment decision with interference." Stat (Int Stat Inst).;8(1). PubMed |
|
Tan Z, Qin G, Zhou H. "Estimation of a partially linear additive model for data from an outcome-dependent sampling design with a continuous outcome." Biostatistics.;17(4):663-76. PubMed |
|
Wages NA, Ivanova A, Marchenko O. "Practical designs for Phase I combination studies in oncology." J Biopharm Stat.;26(1):150-66. PubMed |
|
Wang T, Wang X, Zhou H, Cai J, George SL. "Auxiliary variable-enriched biomarker-stratified design." Stat Med.;37(30):4610-4635. PubMed |
|
Wang X, Ma J, George S, Zhou H. "Estimation of AUC or Partial AUC under test-result-dependent sampling." Stat Biopharm Res.;4(4):313-323. PubMed |
|
Wang X, Zhou J, Wang T, George SL. "On enrichment strategies for biomarker stratified clinical trials." J Biopharm Stat.;28(2):292-308. PubMed |
|
Wang X, Berry MF. "Risk calculators are useful but...." J Thorac Cardiovasc Surg.;151(3):706-707. PubMed |
|
Wang X, Ma J, George SL. "ROC curve estimation under test-result-dependent sampling." Biostatistics.;14(1):160-72. PubMed |
|
Wang X, Wang X, Hodgson L, George SL, Sargent DJ, Foster NR, Ganti AKishor, Stinchcombe TE, Crawford J, Kratzke R, Adjei AA, Kindler HL, Vokes EE, Pang H. "Validation of progression-free survival as a surrogate endpoint for overall survival in malignant mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials." Oncologist.;22(2):189-198. PubMed |
|
Wang X, Gu L, Zhang Y, Sargent DJ, Richards W, Ganti AKishor, Crawford J, Cohen HJay, Stinchcombe T, Vokes E, Pang H. "Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups." Lung Cancer.;90(2):281-7. PubMed |
|
Wu Y, Chambers CD, Xu R. "Semiparametric sieve maximum likelihood estimation under cure model with partly interval censored and left truncated data for application to spontaneous abortion." Lifetime Data Anal.;25(3):507-528. PubMed |
|
Xia F, George SL, Wang X. "A multi-state model for designing clinical trials for testing overall survival allowing for crossover after progression." Stat Biopharm Res.;8(1):12-21. PubMed |
|
Xiao W, Lu W, Zhang HHelen. "Joint structure selection and estimation in the time-varying coefficient Cox model. " Stat Sin.;26(2):547-567. PubMed |
|
Xue X, Foster MC, Ivanova A. "Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups." J Biopharm Stat.;29(4):625-634. PubMed |
|
Yan Y, Zhou H, Cai J. "Improving efficiency of parameter estimation in case-cohort studies with multivariate failure time data." Biometrics.;73(3):1042-1052. PubMed |
|
Yao XI, Wang X, Speicher PJ, Hwang S, Cheng P, Harpole DH, Berry MF, Schrag D, Pang HH. "Reporting and guidelines in propensity score analysis: A systematic review of cancer and cancer surgical studies." J Natl Cancer Inst.;109(8). PubMed |
|
Yu J, Liu Y, Cai J, Sandler DP, Zhou H. "Outcome-dependent sampling design and inference for Cox's proportional hazards model." J Stat Plan Inference.;178:24-36. PubMed |
|
Yu J, Liu Y, Sandler DP, Zhou H. "Statistical inference for the additive hazards model under outcome-dependent sampling." Can J Stat.;43(3):436-453. PubMed |
|
Yuan J, Pang H, Tong T, Xi D, Guo W, Mesenbrink P. "Seamless phase IIa/IIb and enhanced dose-finding adaptive design." J Biopharm Stat.;26(5):912-23. PubMed |
|
Yuan S, Zhang HHelen, Davidian M. "Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials." Stat Med.;31(29):3789-804. PubMed |
|
Zeng D, Cornea E, Dong J, Pan J, Ibrahim JG. "Assessing temporal agreement between central and local progression-free survival times." Stat Med.;34(5):844-58. PubMed |
|
Zeng D, Chen Q, Chen MH, Ibrahim JG. "Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study." Biometrika.;99(1):167-184. PubMed |
|
Zeng D, Gao F, Hu K, Jia C, Ibrahim JG. "Hypothesis testing for two-stage designs with over or under enrollment." Stat Med.;34(16):2417-26. PubMed |
|
Zeng D, Ibrahim JG, Chen MH, Hu K, Jia C. "Multivariate recurrent events in the presence of multivariate informative censoring with applications to bleeding and transfusion events in myelodysplastic syndrome." J Biopharm Stat.;24(2):429-42. PubMed |
|
Zeng D, Hyun N, Cai J. "Semiparametric additive model for estimating risk difference in multicenter studies." Biostat Epidemiol.;2(1):84-98. PubMed |
|
Zeng D, Schaubel DE, Cai J. "Semiparametric transformation rate model for recurrent event data." Stat Biosci.;3(2):187-207. PubMed |
|
Zhang Y, Chen MH, Ibrahim JG, Zeng D, Chen Q, Pan Z, Xue X. "Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching." Lifetime Data Anal.;20(1):76-105. PubMed |
|
Zhang J, Liang W, Liang H, Wang X, He J. "Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analyses." Ann Transl Med.;7(11):244. PubMed |
|
Zhang H, Zeng D, Olschwang S, Yu K. "Semiparametric inference on the penetrances of rare genetic mutations based on a case-family design." J Stat Plan Inference.;143(2):368-377. PubMed |
|
Zhao Y, Herring AH, Zhou H, Ali MW, Koch GG. "A multiple imputation method for sensitivity analyses of time-to-event data with possibly informative censoring." J Biopharm Stat.;24(2):229-53. PubMed |
|
Zhao Y, Saville BR, Zhou H, Koch GG. "Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment." J Biopharm Stat.;26(2):269-79. PubMed |
|
Zhou J, Zhang J, Mclain AC, Lu W, Sui X, Hardin JW. "A varying-coefficient generalized odds rate model with time-varying exposure: An application to fitness and cardiovascular disease mortality." Biometrics.;75(3):853-863. PubMed |
|
Zhou J, Zhang J, Lu W. "An Expectation Maximization algorithm for fitting the generalized odds-rate model to interval censored data." Stat Med.;36(7):1157-1171. PubMed |
|
Zhou F, Zhou H, Li T, Zhu H. "Analysis of secondary phenotypes in multigroup association studies." Biometrics.;76(2):606-618. PubMed |
|
Zhou Q, Zhou H, Cai J. "Case-cohort studies with interval-censored failure time data." Biometrika.;104(1):17-29. PubMed |
|
Zhou J, Zhang J, Lu W. "Computationally efficient estimation for the generalized odds rate mixture cure model with interval censored data" J Comput Graph Stat.;27(1):48-58. PubMed |
|
Zhou Q, Cai J, Zhou H. "Outcome-dependent sampling with interval-censored failure time data." Biometrics.;74(1):58-67. PubMed |
|
Zhou H, Wu Y, Liu Y, Cai J. "Semiparametric inference for a 2-stage outcome-auxiliary-dependent sampling design with continuous outcome." Biostatistics.;12(3):521-34. PubMed |
|
Zhou Q, Cai J, Zhou H. "Semiparametric inference for a two-stage outcome-dependent sampling design with interval-censored failure time data." Lifetime Data Anal.;26(1):85-108. PubMed |
|
Zhou H, Xu W, Zeng D, Cai J. "Semiparametric inference for data with a continuous outcome from a two-phase probability dependent sampling scheme." J R Stat Soc Series B Stat Methodol.;76(1):197-215. PubMed |
|
Zhu Z, Wang X, Saha-Chaudhuri P, Kosinski AS, George SL. "Time-dependent classification accuracy curve under marker-dependent sampling." Biom J.;58(4):974-92. PubMed |
|
Zou B, Cai J, Koch GG, Zhou H, Zou F. "A model-based conditional power assessment for decision making in randomized controlled trial studies. " Stat Med.;36(30):4765-4776. PubMed |
|
Zou B, Jin B, Koch GG, Zhou H, Borst SE, Menon S, Shuster JJ. "On model selections for repeated measurement data in clinical studies." Stat Med.;34(10):1621-33. PubMed |
|
Zou B, Zou F, Shuster JJ, Tighe PJ, Koch GG, Zhou H. "On variance estimate for covariate adjustment by propensity score analysis." Stat Med.;35(20):3537-48. PubMed |
